Verition Fund Management
TLSI icon

Verition Fund Management’s TriSalus Life Sciences TLSI Stock Holding History

Verition Fund Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-611,128
Closed -$6.07M – 2724
2022
Q3 		$6.07M Sell
611,128
-14,800
-2% -$146K 0.07% 346
2022
Q2 		$6.16M Buy
625,928
+48,546
+8% +$477K 0.12% 200
2022
Q1 		$5.66M Buy
577,382
+535,109
+1,266% +$5.28M 0.07% 334
2021
Q4 		$417K Hold
42,273
– – ﹤0.01% 1806
2021
Q3 		$419K Sell
42,273
-267,123
-86% -$2.61M ﹤0.01% 1301
2021
Q2 		$3.02M Buy
309,396
+769
+0.2% +$7.54K 0.03% 375
2021
Q1 		$2.98M Buy
+308,627
New +$3.13M 0.03% 308

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management's TLSI Position: Q4 2022 in Review

Verition Fund Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 611,128 shares — an estimated $6.07M sold.

Verition Fund Management first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $6.16M in Q2 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Verition Fund Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 611,128 TriSalus Life Sciences shares in Q4 2022, an estimated $6.07M.
  • Verition Fund Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • Verition Fund Management's TriSalus Life Sciences position peaked at $6.16M in Q2 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.